(Q34268899)

1 August 2017

1 reference

title

Alzheimer's disease and estrogen (English)

1 reference

1 August 2017

0 references

Honjo H

1

1 reference

1 August 2017

Kikuchi N

2

1 reference

1 August 2017

Hosoda T

3

1 reference

1 August 2017

Kariya K

4

1 reference

1 August 2017

Kinoshita Y

5

1 reference

1 August 2017

Iwasa K

6

1 reference

1 August 2017

Ohkubo T

7

1 reference

1 August 2017

Tanaka K

8

1 reference

1 August 2017

Tamura T

9

1 reference

1 August 2017

Urabe M

10

1 reference

1 August 2017

Kawata M

11

1 reference

1 August 2017

publication date

1 January 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 August 2017

published in

1 reference

1 August 2017

volume

76

1 reference

1 August 2017

issue

1-5

1 reference

1 August 2017

page(s)

227-230

1 reference

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Senile dementia-Alzheimer's type and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Estrogen replacement therapy and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900152-7

7 January 2021

10.1016/S0960-0760(00)00152-7

Identifiers

DOI

1 reference

1 August 2017

1 reference